Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid Arthritis
Conditions: Systemic Lupus Erythematosus; Rheumatoid Arthritis Interventions: Drug: PF-06835375; Drug: Placebo Sponsor: Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials